Table 1.
Lockdown (2020) | Reference (2019) | ||
---|---|---|---|
n (%) | n (%) | p | |
All cases | 366 | 408 | |
Caller site | < .001 | ||
PVa | 308 (84.0)* | 251 (61.5) | |
H/EDb | 58 (16.0)* | 157 (38.5) | |
Age group (years) | .363 | ||
≤ 6 | 112 (30.7) | 121 (29.7) | |
7–18 | 21 (5.5) | 32 (7.8) | |
≥ 19 | 233 (63.8) | 255 (62.5) | |
Site of exposure | .287 | ||
Home | 327 (89.3) | 349 (85.5) | |
Public and open spaces | 25 (6.9) | 37 (9.1) | |
Workplace and community | 14 (3.8) | 22 (5.4) | |
Agent category | < .001 | ||
Medications | 68 (18.7)* | 161 (39.5) | |
Household and cleaning products | 131 (35.9)* | 109 (26.7) | |
Pesticides | 22 (6.0)* | 9 (2.2) | |
Solvents and fuels | 20 (5.4) | 24 (5.9) | |
Substances of abuse | 4 (1.1) | 4 (1.0) | |
Food | 14 (3.8) | 19 (4.7) | |
Mushrooms and plants | 13 (3.7) | 10 (2.4) | |
Animal bites and stings | 30 (8.1) | 23 (5.6) | |
HMPc and CAMd | 15 (4.1) | 9 (2.2) | |
Other toxic products | 15 (4.0) | 11 (2.7) | |
Non-toxic products | 34 (9.2) | 29 (7.1) | |
Reason of exposure | < .001 | ||
Unintentional | 280 (76.4)* | 233 (57.1) | |
Intentional | 39 (10.7)* | 74 (18.1) | |
Adverse reactions | 3 (0.8) | 8 (2.0) | |
Administration error | 42 (11.5)* | 87 (21.3) | |
Unknown | 2 (0.6) | 6 (1.5) | |
Route of exposure | .185 | ||
Ingestion | 228 (62.3) | 291 (71.3) | |
Inhalation | 50 (13.7) | 39 (9.6) | |
Inoculation | 14 (3.8) | 14 (3.4) | |
Bites | 19 (5.2) | 10 (2.5) | |
Dermal | 18 (4.9) | 16 (3.9) | |
Oral mucosa | 22 (6.0) | 22 (5.4) | |
Ocular | 12 (3.3) | 9 (2.2) | |
Other and unknown | 3 (0.8) | 7 (1.7) |
*z-test with Bonferroni correction (p < .05)
aPV private citizens
bH/ED hospitals and emergency department
cHMP herbal medicinal products
dCAM complementary and alternative medicine